Transition Therapeutics, Opko deal

Opko will acquire Transition for $1.55 per share, or about $60 million, in a stock deal. The price is a 121%

Read the full 211 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE